The Future of Regenerative Medicine is Here! OpenAI and Retro Biosciences have teamed up to develop *GPT-4b Micro*, an AI model designed to revolutionize stem cell production. - *AI-Driven Protein Engineering:* GPT-4b Micro suggests modifications to Yamanaka factors, enabling *50x more effective stem cell creation* than traditional methods. - *Regenerative Medicine Breakthrough:* Dramatically improves efficiency, cutting down time and boosting success rates for stem cell generation. This AI-powered leap could lead to better treatments for age-related diseases, organ replacement, and personalized medicine—making regenerative therapies more accessible and effective. PS:AI isn’t just changing tech—it’s redefining what’s possible in healthcare. The future of medicine just got a whole lot smarter!